MBVX Insider Trading Activity and SEC Form 4 Filings
MBVX insider trading summary
No open-market insider purchases or sales of Mabvax Therapeutics Holdings, Inc. (MBVX) have been reported on SEC Form 4 in the past 12 months.
Latest MBVX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 24, 2018 | Jeffrey F Eisenberg | Insider | Sell | $15K (17,998 @ $0.84) |
| Jan 24, 2018 | Paul V Maier | Insider | Sell | $15K (17,999 @ $0.84) |
| Jan 24, 2018 | Thomas C Varvaro | Insider | Sell | $15K (17,996 @ $0.84) |
| Jan 24, 2018 | Kenneth M Cohen | Insider | Sell | $15K (17,996 @ $0.84) |
| Jan 23, 2018 | Kenneth M Cohen | Insider | Sell | $15K (17,444 @ $0.87) |
| Jan 23, 2018 | Thomas C Varvaro | Insider | Sell | $15K (17,445 @ $0.87) |
| Jan 23, 2018 | Jeffrey F Eisenberg | Insider | Sell | $15K (17,444 @ $0.87) |
| Jan 23, 2018 | Paul V Maier | Insider | Sell | $15K (17,449 @ $0.87) |
| Jan 16, 2018 | John David Hansen | President and CEO | Sell | $55K (59,263 @ $0.92) |
| Jan 16, 2018 | Paul F Resnick | Vice President, Cbo | Sell | $3K (3,071 @ $0.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.